Sumatriptan Succinate Tablets
SPE2D223R0003 · DEPT OF DEFENSE
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, performed in Carole Park, AU-ACT. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
Modification SPE2D223D0009 P00007 posted to announce exercising of Option Year Three (3), effective July 25, 2026 through July 24, 2027.
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| THERACOM, L.L.C. | $38K | 1 | 2026-07-02 |
| REGIMED MEDICAL | $293K | 7 | 2026-07-02 |
| SRI INTERNATIONAL | $49.9M | 7 | 2026-07-02 |
| PRIORITY HEALTHCARE DISTRIBUTION INC | $16K | 1 | 2026-07-02 |
| COVERMYMEDS PHARMACY LLC | $16K | 1 | 2026-07-02 |
Questions
What is solicitation SPE2D223R0003?
Sumatriptan Succinate Tablets, issued by DEPT OF DEFENSE, under NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING), performed in Carole Park, AU-ACT.
What do similar contracts close for?
Comparable closed awards in this category ran from $16K to $49.9M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.